Get the Stockscreener App
2.98
3.56%
-0.11
After Hours:
2.96
-0.02
-0.67%
Sonoma Pharmaceuticals Inc stock is traded at $2.98, with a volume of 51,975.
It is down -3.56% in the last 24 hours and up +4.75% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$3.09
Open:
$3.09
24h Volume:
51,975
Relative Volume:
0.72
Market Cap:
$4.90M
Revenue:
$12.31M
Net Income/Loss:
$-5.08M
P/E Ratio:
-3.1702
EPS:
-0.94
Net Cash Flow:
$-5.20M
1W Performance:
-17.13%
1M Performance:
+4.75%
6M Performance:
+10.78%
1Y Performance:
-59.18%
1-Day Range:
$2.98
$3.20
1-Week Range:
$2.98
$3.655
52-Week Range:
$1.75
$7.70
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
2.98 | 5.08M | 12.31M | -5.08M | -5.20M | -0.94 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
Strategies to average down on Sonoma Pharmaceuticals Inc.Free News Based Entry Opportunity Alerts - Newser
Why Sonoma Pharmaceuticals Inc. stock attracts strong analyst attentionAlgorithmic Prediction of Market Breakouts - Newser
Is Sonoma Pharmaceuticals Inc. Stock a Smart Buy in 2025 Investment Analysis InsideDaily Market Movers Screener with Filters - Newser
Custom strategy builders for tracking Sonoma Pharmaceuticals Inc.Swing Trade Picks with High Potential - Newser
What institutional investors are buying Sonoma Pharmaceuticals Inc. stockTop Growth Data Feed From AI Tools - jammulinksnews.com
Is this a good reentry point in Sonoma Pharmaceuticals Inc.Profit Target Planning with Exit Confidence - Newser
What makes Sonoma Pharmaceuticals Inc. stock price move sharply5-Year Price Trend Summary and Analysis - Newser
News impact scoring models applied to Sonoma Pharmaceuticals Inc.Daily Stock Forecast Powered by AI Tools - Newser
Is Sonoma Pharmaceuticals Inc. stock ready for a breakoutFree Swing Setup With Technical Confirmation - Newser
Volatility clustering patterns for Sonoma Pharmaceuticals Inc.AI Trading Forecast Based on Big Data - Newser
Using Python tools to backtest Sonoma Pharmaceuticals Inc. strategiesFree Sector Based Breakout Stock Forecast - Newser
Smart tools for monitoring Sonoma Pharmaceuticals Inc.’s price actionIntraday Movement Recap and Chart Summary - Newser
Moving Average Crossover Confirms Uptrend in Sonoma Pharmaceuticals Inc.AI Driven Buy Alert Trade Blueprint Released - metal.it
Visualizing Sonoma Pharmaceuticals Inc. stock with heatmapsFree AI Forecast for Trending Stocks - Newser
Tools to monitor Sonoma Pharmaceuticals Inc. recovery probabilityLong-Term Stock Growth Forecast Insights - Newser
Moving Average Trends for Sonoma Pharmaceuticals Inc. Stock: What They IndicateReal Time Trade Execution Alert Plan - Newser
Has Sonoma Pharmaceuticals Inc. Stock Ever Crashed Historical Volatility ReviewFree Trade Scanner With Buy Zone Alerts - Newser
Will Sonoma Pharmaceuticals Inc. stock split in the near futureFree Watchlist for Low Risk High Return - Newser
What are the technical indicators suggesting about Sonoma Pharmaceuticals Inc.Stay informed with daily expert analysis - jammulinksnews.com
Understanding Sonoma Pharmaceuticals Inc.’s price movementFree Pattern Alert With ROI Driven Strategy - Newser
Is it the right time to buy Sonoma Pharmaceuticals Inc. stockUnlock exclusive stock market forecasts - jammulinksnews.com
How does Sonoma Pharmaceuticals Inc. generate profit in a changing economyOutstanding risk-reward balance - jammulinksnews.com
Is Sonoma Pharmaceuticals Inc. a growth stock or a value stockBuild a diversified portfolio for sustainable growth - jammulinksnews.com
Is Sonoma Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025Safe and Scalable Investment Tips - metal.it
Is Sonoma Pharmaceuticals Inc. Stock Overbought or Oversold RSI Indicator AnalysisMassive Profit Potential - Newser
What drives Sonoma Pharmaceuticals Inc. stock priceHigh-octane financial growth - PrintWeekIndia
Is Sonoma Pharmaceuticals Inc. stock overhyped or has real potentialSuperior portfolio returns - jammulinksnews.com
What analysts say about Sonoma Pharmaceuticals Inc. stockHigh-margin investment plays - PrintWeekIndia
Is Sonoma Pharmaceuticals Inc. a good long term investmentUnrivaled growth potential - Autocar Professional
Sonoma Pharmaceuticals Inc. Stock Analysis and ForecastStrong return on investment - Autocar Professional
How high can Sonoma Pharmaceuticals Inc. stock price go in 2025Powerful market insights - jammulinksnews.com
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):